Linaclotide for treatment of irritable bowel syndrome--the view of European regulators

Dig Liver Dis. 2013 Sep;45(9):724-6. doi: 10.1016/j.dld.2013.03.017. Epub 2013 May 21.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Constipation / drug therapy*
  • Constipation / etiology
  • Drug Approval*
  • Europe
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Irritable Bowel Syndrome / complications
  • Irritable Bowel Syndrome / drug therapy*
  • Peptides / therapeutic use*
  • Receptors, Enterotoxin
  • Receptors, Guanylate Cyclase-Coupled / agonists
  • Receptors, Peptide / agonists
  • Treatment Outcome

Substances

  • Gastrointestinal Agents
  • Peptides
  • Receptors, Peptide
  • Receptors, Enterotoxin
  • Receptors, Guanylate Cyclase-Coupled
  • linaclotide